These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21061542)
1. [A genetic background of ulcer diseases induced by NSAID/aspirin]. Arisawa T; Tahara T; Nakamura M Nihon Rinsho; 2010 Nov; 68(11):2113-8. PubMed ID: 21061542 [TBL] [Abstract][Full Text] [Related]
2. [Genetic polymorphism of COX-1 gene and NSAID-induced ulcer]. Arisawa T; Hirata I Nihon Rinsho; 2007 Oct; 65(10):1885-9. PubMed ID: 17926541 [TBL] [Abstract][Full Text] [Related]
3. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan. Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Nakamura M; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H Int J Mol Med; 2007 Sep; 20(3):373-8. PubMed ID: 17671743 [TBL] [Abstract][Full Text] [Related]
5. Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirin. Wang PY; Chen HP; Chen A; Tsay FW; Lai KH; Kao SS; Chen WC; Kuo CH; Peng NJ; Tseng HH; Hsu PI Biomed Res Int; 2014; 2014():616018. PubMed ID: 25243161 [TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
7. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
8. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106 [TBL] [Abstract][Full Text] [Related]
9. Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Musumba C; Pritchard DM; Pirmohamed M Aliment Pharmacol Ther; 2009 Sep; 30(6):517-31. PubMed ID: 19575764 [TBL] [Abstract][Full Text] [Related]
14. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey. Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405 [TBL] [Abstract][Full Text] [Related]
15. One hundred years of NSAID gastropathy: are coxibs the answer? Bjorkman DJ Rev Gastroenterol Disord; 2001; 1(3):121-7. PubMed ID: 12120179 [TBL] [Abstract][Full Text] [Related]
16. Specifics of Helicobacter pylori infection/NSAID effects in the elderly. Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236 [TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention. Scheiman JM Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226 [TBL] [Abstract][Full Text] [Related]